JD MED

Active

Private limited companyfounded 20223 yrs activeRue Bois de l'Abbaye 2, 4100 Seraing, BelgiumKBO/BCE: BE 0792.353.606

Summary

The computed 12-month bankruptcy probability of JD MED is 2.7% (moderate). The 2025 annual accounts show equity of €96,464 and a net result of €93,834. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch Report Compare

JD MEDActiveChecked score 68/100

Risk analysis Report Compare

What they do

Activity not known1 site

How big

€241,450total assets 2025

Equity: €96,464
Profit: €93,834

Turnover not published (abridged schema)

Financially healthy?

68 Healthy Checked score 2025

Bankruptcy chance 12 m: 2.7%

Who decides

Accounts filed 29 d late0 of 1 deed read

Why 68- Limited track record- No NACE activity registered- Higher-failure-rate region+ Annual accounts: healthy financial profileA punctual record breaksShow the evidence

Checked score

Score 2025

68 / 100

Healthy

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability100=

Solvency65▼-35

Growth78=

Track record94

Bankruptcy probability, 12 months

2.7% Moderate

0%0.5%1.5%4%10%≥ 25%

Credit up to €6,000 at 30 days acceptable

Liquidity ample (current ratio 1.61; short-term debt: 59.6% and cash: 71.8% of total assets), but 60% of the assets are financed with debt.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

No NACE activity registered

No NACE activity is registered in the KBO, which is more common among companies that later fail.

KBO · activities

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

40%

Return on assets

38.9%

Age of the figures

9 mo

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

A punctual record breaks

This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-08-2026, 29 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.

NBB · 4 filings

Deviation from the deadline

2025

29 d late

2024

1 d early

2023

37 d early

2022

54 d early

← before the deadline after the deadline →

tick = median of all Belgian filings

This company filed its last 4 accounts on average 16 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 13 July (3 of the last 4 filed years within 36 days of that day).

Companies Code · seven months

Position in the running window

02-10-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage